Shares of Francesca’s Holdings Corporation (NASDAQ: FRAN) jumped 91% in morning hours on Tuesday following the company’s second quarter 2019 earnings announcement.
Net sales dropped 6% year-over-year to $106 million due to a 5% decrease in comparable sales. The comp sales decline was driven by lower average unit retail prices related to deeper markdowns on legacy products. This decline was partially offset by higher boutique conversion rates and average units per transaction.
The company reported net income of $1.8 million, or $0.61 per share, compared to $0.5 million, or $0.16 per share, in the year-ago period. Adjusted net income was $2.1 million, or $0.72 per share.
Gross profit, as a percent of net sales, decreased to 38.2% from 39% in the prior year quarter, driven by lower merchandise margins due to deeper markdowns on legacy products and deleveraging of occupancy costs as a result of lower sales.
SG&A expenses dropped 10% to $39.1 million. The company realized material savings during the quarter through a number of cost reduction initiatives it has been executing since the beginning of the year.
During the quarter, Francesca’s opened one new boutique and closed five boutiques, bringing the total boutique count to 718 at the end of the period.
At quarter-end, the company had $30.9 million of inventory on hand compared to $31.9 million in the same period last year. Average ending inventory per boutique was flat at $43,000 versus the prior-year period.
Last month, activist investor Cross River Management disclosed a 22% stake in Francesca’s and stated they were engaged with the board and management, according to a report by MarketWatch.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
Comments
Comments are closed.